Madrigal Pharmaceuticals Inc. (MDGL)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Madrigal Pharmaceuticals Statistics
Share Statistics
Madrigal Pharmaceuticals has 21.81M shares outstanding. The number of shares has increased by 9.61% in one year.
Shares Outstanding | 21.81M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.45% |
Owned by Institutions (%) | n/a |
Shares Floating | 18.39M |
Failed to Deliver (FTD) Shares | 2.21K |
FTD / Avg. Volume | 0.47% |
Short Selling Information
The latest short interest is 4.73M, so 21.71% of the outstanding shares have been sold short.
Short Interest | 4.73M |
Short % of Shares Out | 21.71% |
Short % of Float | 25.75% |
Short Ratio (days to cover) | 12.58 |
Valuation Ratios
The PE ratio is -11.57 and the forward PE ratio is -24.29.
PE Ratio | -11.57 |
Forward PE | -24.29 |
PS Ratio | 0 |
Forward PS | 6.9 |
PB Ratio | 10.67 |
P/FCF Ratio | -13.28 |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Madrigal Pharmaceuticals Inc..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.38, with a Debt / Equity ratio of 0.29.
Current Ratio | 5.38 |
Quick Ratio | 5.38 |
Debt / Equity | 0.29 |
Total Debt / Capitalization | 22.43 |
Cash Flow / Debt | -2.77 |
Interest Coverage | -29.93 |
Financial Efficiency
Return on equity (ROE) is -0.92% and return on capital (ROIC) is -72.82%.
Return on Equity (ROE) | -0.92% |
Return on Assets (ROA) | -0.58% |
Return on Capital (ROIC) | -72.82% |
Revenue Per Employee | 0 |
Profits Per Employee | -993.70K |
Employee Count | 376 |
Asset Turnover | 0 |
Inventory Turnover | 0 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 45.49% in the last 52 weeks. The beta is -0.47, so Madrigal Pharmaceuticals 's price volatility has been lower than the market average.
Beta | -0.47 |
52-Week Price Change | 45.49% |
50-Day Moving Average | 315.26 |
200-Day Moving Average | 261.92 |
Relative Strength Index (RSI) | 57.16 |
Average Volume (20 Days) | 471.97K |
Income Statement
Revenue | n/a |
Gross Profit | -527.00K |
Operating Income | -380.50M |
Net Income | -373.63M |
EBITDA | -379.97M |
EBIT | n/a |
Earnings Per Share (EPS) | -19.99 |
Balance Sheet
The company has 99.92M in cash and 117.19M in debt, giving a net cash position of -17.28M.
Cash & Cash Equivalents | 99.92M |
Total Debt | 117.19M |
Net Cash | -17.28M |
Retained Earnings | -1.34B |
Total Assets | 1.07B |
Working Capital | 885.82M |
Cash Flow
In the last 12 months, operating cash flow was -324.23M and capital expenditures -1.48M, giving a free cash flow of -325.71M.
Operating Cash Flow | -324.23M |
Capital Expenditures | -1.48M |
Free Cash Flow | -325.71M |
FCF Per Share | -17.43 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MDGL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -6.16% |
FCF Yield | -4.6% |
Analyst Forecast
The average price target for MDGL is $377, which is 16.2% higher than the current price. The consensus rating is "Buy".
Price Target | $377 |
Price Target Difference | 16.2% |
Analyst Consensus | Buy |
Analyst Count | 13 |
Stock Splits
The last stock split was on Jul 25, 2016. It was a backward split with a ratio of 1:35.
Last Split Date | Jul 25, 2016 |
Split Type | backward |
Split Ratio | 1:35 |
Scores
Altman Z-Score | 10.22 |
Piotroski F-Score | 4 |
We use cookies to ensure that we give you the best experience on our website. Read Privacy Policy.